EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma

Jiawen Song

OncoTargets and Therapy · 2026-09 · Volume 19 · 1-14

DOI: 10.2147/ott.s620767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-09. Verfasst von Jiawen Song. Beteiligte Einrichtung: Shanghai Fengxian District Central Hospital, Shanghai, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

aurora kinase Adrug repurposingesophageal squamous cell carcinomaneoadjuvant therapyperioperative safety

Autor:innen und Institutionen

  • Shanghai Fengxian District Central Hospital, Shanghai, China.

Zitieren

APA

Song, J. (2026). Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma. OncoTargets and Therapy, Volume 19, 1-14. https://doi.org/10.2147/ott.s620767

Vancouver

Song J. Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma. OncoTargets and Therapy. 2026;Volume 19:1-14. doi:10.2147/ott.s620767

BibTeX
@article{Song2026,
  author = {Song, Jiawen},
  title = {Dipyridamole as a Perioperatively Safe Aurora Kinase A Inhibitor for Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--14},
  doi = {10.2147/ott.s620767}
}
Kostenlos starten →